Maha Saad

Maha Saad

Auto-generated profile, based on publicly available information

Maha Saad

St. John's University College of Pharmacy and Health Sciences Queens New York USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
MGMicheline Andel Goldwire
Micheline Andel Goldwire
SJSteven T. Johnson
Steven T. Johnson
MAMaha Abdalla
Maha Abdalla
AAAshish Advani
Ashish Advani
ABAllison Bernknopf
Allison Bernknopf
KWKristina Ward
Kristina Ward

26 October 2025 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
MAMaha Abdalla
Maha Abdalla
MSMaha Saad
Maha Saad
DADaniel Abazia
Daniel Abazia
AAAshish Advani
Ashish Advani
AAAbdullah M. Alhammad
Abdullah M. Alhammad
KTKrisy‐Ann Thornby
Krisy‐Ann Thornby

21 March 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
SJSteven Theodore Johnson
Steven Theodore Johnson
MGMicheline Andel Goldwire
Micheline Andel Goldwire
MAMaha Abdalla
Maha Abdalla
WAWafa Saad Alshehri
Wafa Saad Alshehri
ABAllison Bernknopf
Allison Bernknopf
KWKristina E. Ward
Kristina E. Ward

31 July 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
SJSteven Theodore Johnson
Steven Theodore Johnson
MGMicheline Andel Goldwire
Micheline Andel Goldwire
MAMaha Abdalla
Maha Abdalla
AAAshish Advani
Ashish Advani
AAAbdullah M. Alhammad
Abdullah M. Alhammad
CSChristine D. Sommer
Christine D. Sommer

20 February 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
AIAdriane N Irwin
Adriane N Irwin
SSSarah A. Spinler
Sarah A. Spinler
JBJordan Baye
Jordan Baye
MBMarilyn N. Bulloch
Marilyn N. Bulloch
SBSummer D. Byerley
Summer D. Byerley
DYDinesh Yogaratnam
Dinesh Yogaratnam

29 July 2025 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MSMaha Saad
Maha Saad
NMNicole M. Maisch
Nicole M. Maisch
Celiac disease can significantly impair levothyroxine absorption, complicating hypothyroidism management despite appropriate dosing. While a gluten-free diet often improves absorption, some patients continue to require high doses. Switching to liquid or softgel formulations can enhance levothyroxine bioavailability and symptom control. Optimizing therapy requires individualized approaches, including dietary intervention, formulation changes, and close monitoring, to achieve and maintain a euthyroid state. Relevant studies were reviewed and incorporated into this commentary to support evidence-based recommendations and highlight clinical considerations.